Back
Geron 10K Form
Sell
30
GERN
Geron
Last Price:
$1.64
Seasonality Move:
21.78%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | GERN/Geron Quarterly |
| 2023-11-02 | 10Q | GERN/Geron Quarterly |
| 2023-08-03 | 10Q | GERN/Geron Quarterly |
| 2023-05-11 | 10Q | GERN/Geron Quarterly |
| 2022-11-07 | 10Q | GERN/Geron Quarterly |
| 2022-08-11 | 10Q | GERN/Geron Quarterly |
Receive GERN News And Ratings
See the #1 stock for the next 7 days that we like better than GERN
GERN Financial Statistics
Sales & Book Value
| Annual Sales: | $77M |
|---|---|
| Cash Flow: | $-43.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.46 |
| Price / Book: | 3.73 |
Profitability
| EPS (TTM): | -0.27000 |
|---|---|
| Net Income (TTM): | $-174.6M |
| Gross Margin: | $75.7M |
| Return on Equity: | -59.29% |
| Return on Assets: | -36.92% |
Geron Earnings Forecast
Key Geron Financial Ratios
-
The Gross Profit Margin over the past 24 years for GERN is 98.37%.
-
The Selling, General & Administrative Expenses for GERN have been equal to 189.28% of Gross Profit Margin.
-
The Research & Development expenses have been 134.74% of Revenue.
-
The Net Earning history of GERN is -226.73% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 17 years.
Geron Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GERN |
| CUSIP: | 374163 |
| Website: | geron.com |
Debt
| Debt-to-Equity Ratio: | 0.42 |
|---|---|
| Current Ratio: | 5.56 |
| Quick Ratio: | 5.04 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 45.53 |